Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer

Wilms tumor gene (WT1) protein is an attractive target for cancer immunotherapy. We aimed to investigate the feasibility of a combination therapy consisting of gemcitabine and WT1 peptide–based vaccine for patients with advanced pancreatic cancer and to make initial assessments of its clinical effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Sumiyuki, Koido, Shigeo, Takeda, Yutaka, Homma, Sadamu, Komita, Hideo, Takahara, Akitaka, Morita, Satoshi, Ito, Toshinori, Morimoto, Soyoko, Hara, Kazuma, Tsuboi, Akihiro, Oka, Yoshihiro, Yanagisawa, Satoru, Toyama, Yoichi, Ikegami, Masahiro, Kitagawa, Toru, Eguchi, Hidetoshi, Wada, Hiroshi, Nagano, Hiroaki, Nakata, Jun, Nakae, Yoshiki, Hosen, Naoki, Oji, Yusuke, Tanaka, Toshio, Kawase, Ichiro, Kumanogoh, Atsushi, Sakamoto, Junichi, Doki, Yuichiro, Mori, Masaki, Ohkusa, Toshifumi, Tajiri, Hisao, Sugiyama, Haruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229357/
https://www.ncbi.nlm.nih.gov/pubmed/24509173
http://dx.doi.org/10.1097/CJI.0000000000000020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229357/
https://www.ncbi.nlm.nih.gov/pubmed/24509173
http://dx.doi.org/10.1097/CJI.0000000000000020

Ejemplares similares